Robin Munro

Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis

Robin Munro, E Morrison, A G McDonald et al. · Annals of the Rheumatic Diseases · 1997 · 134 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial

Duncan Porter, Jurgen van Melckebeke, James Dale et al. · The Lancet · 2016 · 119 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response

Robin Munro, H A Capell · Annals of the Rheumatic Diseases · 1997 · 114 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study

Robin Munro, Anne McEntegart, E A Thomson et al. · Annals of the Rheumatic Diseases · 1998 · 114 citations

Medicine, Internal Medicine, Pharmacotherapy +17

Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

H A Capell, Rajan Madhok, Duncan Porter et al. · Annals of the Rheumatic Diseases · 2006 · 109 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13